{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Arrhythmogenic Right Ventricular Cardiomyopathy",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_sotalol",
          "type": "Drug",
          "label": "Sotalol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dofetilide",
          "type": "Drug",
          "label": "Dofetilide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_amiodarone",
          "type": "Drug",
          "label": "Amiodarone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_flecainide",
          "type": "Drug",
          "label": "Flecainide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_propranolol",
          "type": "Drug",
          "label": "Propranolol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_carvedilol",
          "type": "Drug",
          "label": "Carvedilol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_metoprolol",
          "type": "Drug",
          "label": "Metoprolol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dronedarone",
          "type": "Drug",
          "label": "Dronedarone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_disopyramide",
          "type": "Drug",
          "label": "Disopyramide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mexiletine",
          "type": "Drug",
          "label": "Mexiletine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ibutilide",
          "type": "Drug",
          "label": "Ibutilide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ranolazine",
          "type": "Drug",
          "label": "Ranolazine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "arrhythmogenic_right_ventricular_cardiomyopathy",
          "type": "Disease",
          "label": "Arrhythmogenic Right Ventricular Cardiomyopathy",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_ion_channels",
          "type": "Target",
          "label": "Ion Channels",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_cellular_electrophysiology",
          "type": "Pathway",
          "label": "Cellular Electrophysiology",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_arrhythmia",
          "type": "Phenotype",
          "label": "Arrhythmia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "off_target_sotalol",
          "type": "Target",
          "label": "Off Target - Sotalol",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "risk_pathway_sotalol",
          "type": "Pathway",
          "label": "Risk Pathway - Sotalol",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "adverse_phenotype_sotalol",
          "type": "Phenotype",
          "label": "Adverse Phenotype - Sotalol",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "off_target_dofetilide",
          "type": "Target",
          "label": "Off Target - Dofetilide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "risk_pathway_dofetilide",
          "type": "Pathway",
          "label": "Risk Pathway - Dofetilide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "adverse_phenotype_dofetilide",
          "type": "Phenotype",
          "label": "Adverse Phenotype - Dofetilide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Sotalol",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Dofetilide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Amiodarone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Flecainide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Propranolol",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Carvedilol",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Metoprolol",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Dronedarone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Disopyramide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Mexiletine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Ibutilide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Ranolazine",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_sotalol",
          "target": "target_ion_channels",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知作用于离子通道，调节心律"
        },
        {
          "source": "drug_dofetilide",
          "target": "target_ion_channels",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "作用于钾通道，相关心律失常"
        },
        {
          "source": "drug_amiodarone",
          "target": "target_ion_channels",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "多靶点作用，适用于各种心律失常"
        },
        {
          "source": "drug_flecainide",
          "target": "target_ion_channels",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "了解药理，用于心律失常"
        },
        {
          "source": "drug_propranolol",
          "target": "target_ion_channels",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "调节心率，有助于心室心律失常"
        },
        {
          "source": "drug_carvedilol",
          "target": "target_ion_channels",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "β-adrenergic 蛋白拮抗剂，影响心律"
        },
        {
          "source": "drug_metoprolol",
          "target": "target_ion_channels",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "用于控制心率，常用在心律失常"
        },
        {
          "source": "drug_dronedarone",
          "target": "target_ion_channels",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "作用于心脏的多靶点"
        },
        {
          "source": "drug_disopyramide",
          "target": "target_ion_channels",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "药理作用明确，适用于心律失常"
        },
        {
          "source": "drug_mexiletine",
          "target": "target_ion_channels",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "已知影响心律，适用于早期心律失常"
        },
        {
          "source": "drug_ibutilide",
          "target": "target_ion_channels",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "对心律有直接调控作用"
        },
        {
          "source": "drug_ranolazine",
          "target": "target_ion_channels",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "对心脏电生理有利作用"
        },
        {
          "source": "target_ion_channels",
          "target": "pathway_cellular_electrophysiology",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "离子通道在细胞电生理中重要"
        },
        {
          "source": "pathway_cellular_electrophysiology",
          "target": "phenotype_arrhythmia",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "细胞电生理异常可引起心律失常"
        },
        {
          "source": "target_ion_channels",
          "target": "arrhythmogenic_right_ventricular_cardiomyopathy",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与心律失常直接相关"
        },
        {
          "source": "target_ion_channels",
          "target": "H1",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Sotalol 作为已知作用机制的支持"
        },
        {
          "source": "target_ion_channels",
          "target": "H2",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Dofetilide 作为已知作用机制的支持"
        },
        {
          "source": "target_ion_channels",
          "target": "H3",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Amiodarone 作为已知作用机制的支持"
        },
        {
          "source": "target_ion_channels",
          "target": "H4",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Flecainide 作为已知作用机制的支持"
        },
        {
          "source": "drug_sotalol",
          "target": "off_target_sotalol",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响心脏其他功能"
        },
        {
          "source": "off_target_sotalol",
          "target": "risk_pathway_sotalol",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "引发可能的风险通路"
        },
        {
          "source": "risk_pathway_sotalol",
          "target": "adverse_phenotype_sotalol",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良心脏表型"
        },
        {
          "source": "adverse_phenotype_sotalol",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将抵消净获益"
        },
        {
          "source": "drug_dofetilide",
          "target": "off_target_dofetilide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "干扰其他心脏机制"
        },
        {
          "source": "off_target_dofetilide",
          "target": "risk_pathway_dofetilide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "关联潜在风险通路"
        },
        {
          "source": "risk_pathway_dofetilide",
          "target": "adverse_phenotype_dofetilide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致心脏不良表型"
        },
        {
          "source": "adverse_phenotype_dofetilide",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若存在风险，可能抵消疗效"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.54,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.5,
            "safety_risk": 0.15,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.01
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Sotalol Safety",
                "pro": [
                  "drug_sotalol"
                ],
                "con": [
                  "adverse_phenotype_sotalol"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Sotalol 作用于离子通道，能治疗心律失常"
            ],
            "safety_risk": [
              "潜在的心脏不良表型风险未解决"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "安全性问题需要进一步的探讨"
          ]
        },
        {
          "hypothesis_id": "H2",
          "score": 0.52,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.15,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.01
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Dofetilide Safety",
                "pro": [
                  "drug_dofetilide"
                ],
                "con": [
                  "adverse_phenotype_dofetilide"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Dofetilide 明确作用于钾通道"
            ],
            "safety_risk": [
              "影响心脏其他机制，可能导致不良结果"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "安全性和疗效同时存在疑问"
          ]
        },
        {
          "hypothesis_id": "H3",
          "score": 0.58,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.5,
            "safety_risk": 0.15,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.01
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Amiodarone Safety",
                "pro": [
                  "drug_amiodarone"
                ],
                "con": [
                  "adverse_phenotype_amiodarone"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Amiodarone 通作用於多种离子通道"
            ],
            "safety_risk": [
              "可能导致心脏不良反应"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "临床使用中的安全性需进一步验证"
          ]
        },
        {
          "hypothesis_id": "H4",
          "score": 0.56,
          "components": {
            "mechanism_fit": 0.75,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.15,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.01
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Flecainide Safety",
                "pro": [
                  "drug_flecainide"
                ],
                "con": [
                  "adverse_phenotype_flecainide"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Flecainide 是心律失常的治疗药物"
            ],
            "safety_risk": [
              "与潜在的心脏风险相关"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需关注安全性问题的性质"
          ]
        },
        {
          "hypothesis_id": "H5",
          "score": 0.5,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.15,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.02
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.6,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Propranolol Efficacy",
                "pro": [
                  "drug_propranolol"
                ],
                "con": [
                  "adverse_phenotype_propranolol"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Propranolol 用于调节心率"
            ],
            "safety_risk": [
              "心脏不良反应的可能性不可忽视"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "使用条件和疗效尚需验证"
          ]
        },
        {
          "hypothesis_id": "H6",
          "score": 0.55,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.15,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.01
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Carvedilol Efficacy",
                "pro": [
                  "drug_carvedilol"
                ],
                "con": [
                  "adverse_phenotype_carvedilol"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Carvedilol 影响心律与血压"
            ],
            "safety_risk": [
              "伴随的心脏不良反应需考虑"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "可否在特定人群中有效还有待观察"
          ]
        },
        {
          "hypothesis_id": "H7",
          "score": 0.53,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.15,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.01
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Metoprolol ECG Performance",
                "pro": [
                  "drug_metoprolol"
                ],
                "con": [
                  "adverse_phenotype_metoprolol"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Metoprolol 适用于心律失常的情境"
            ],
            "safety_risk": [
              "需考虑不良反应的风险"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "临床数据的支持尚缺乏"
          ]
        },
        {
          "hypothesis_id": "H8",
          "score": 0.5,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.15,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.01
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Dronedarone Efficacy",
                "pro": [
                  "drug_dronedarone"
                ],
                "con": [
                  "adverse_phenotype_dronedarone"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Dronedarone 适用于心脏的多靶点作用"
            ],
            "safety_risk": [
              "可能的心脏不良效应不能忽视"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "使用安全性需在临床上验证"
          ]
        },
        {
          "hypothesis_id": "H9",
          "score": 0.48,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.15,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.01
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Disopyramide Utilization",
                "pro": [
                  "drug_disopyramide"
                ],
                "con": [
                  "adverse_phenotype_disopyramide"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Disopyramide 明确的药理适用于心律失常"
            ],
            "safety_risk": [
              "心脏不良反应问题需解决"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需检查与耐受性相关的风险问题"
          ]
        },
        {
          "hypothesis_id": "H10",
          "score": 0.47,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.15,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.01
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Mexiletine Function",
                "pro": [
                  "drug_mexiletine"
                ],
                "con": [
                  "adverse_phenotype_mexiletine"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Mexiletine 适用于早期心律失常"
            ],
            "safety_risk": [
              "不良效果的风险需评估"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "使用情况下的有效性尚存疑问"
          ]
        },
        {
          "hypothesis_id": "H11",
          "score": 0.49,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.15,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.01
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Ibutilide Risk",
                "pro": [
                  "drug_ibutilide"
                ],
                "con": [
                  "adverse_phenotype_ibutilide"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Ibutilide 可直接控制心律"
            ],
            "safety_risk": [
              "潜在的不良反应不能被忽视"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需确认长期影响的安全性"
          ]
        },
        {
          "hypothesis_id": "H12",
          "score": 0.46,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.15,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.01
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.5,
            "mechanistic_connectivity": true,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Ranolazine Application",
                "pro": [
                  "drug_ranolazine"
                ],
                "con": [
                  "adverse_phenotype_ranolazine"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Ranolazine 有利于心脏电生理"
            ],
            "safety_risk": [
              "心脏不良表现的风险需留意"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "待进一步验证其临床效应"
          ]
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Sotalol Safety",
            "expectation": "探讨 Sotalol 的潜在心脏不良反应并根据结果调整推论",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_sotalol",
            "via": [
              "target_ion_channels"
            ],
            "to": "arrhythmogenic_right_ventricular_cardiomyopathy",
            "success_criteria": "形成至少1条连通路径，支持 H1 的指示",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "讨论 Sotalol 的心脏不良反应风险与其治疗效果的平衡",
          "探讨目标机制支持下的药效持久性"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Dofetilide Safety",
            "expectation": "确定 Dofetilide 的安全性隐患并作出适当修改",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_dofetilide",
            "via": [
              "target_ion_channels"
            ],
            "to": "arrhythmogenic_right_ventricular_cardiomyopathy",
            "success_criteria": "形成至少1条连通路径，支持 H2 的指示",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "Dofetilide 在特定人群中的风险与收益的临床实证",
          "心脏机制干扰中的药效具体情况"
        ]
      }
    ],
    "pruned_hypotheses": [],
    "new_subhypotheses": [],
    "seed_request": {
      "should_regenerate": false,
      "reason": "当前假设间安全性风险冲突较高，通过补充机制路径可增加支撑证据，优先改善图结构。",
      "n": 4
    }
  }
}